Citations

Mayo Clinic

Showing 10 of 108523 citations.

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Boddicker, Rebecca L., Kip, N. Sertac, Xing, Xiaoming , Zeng, Yu , Yang, Zhi‐Zhang, Lee, Jeong‐Heon , Almada, Luciana L. , Elsawa, Sherine F. , Knudson, Ryan A., Ketterling, Rhett P. , Cunningham, Julie M. , Wu, Yanhong , O’Byrne, Megan M., Link, Brian K. , Porcher, Julie C., Grote, Deanna M., Jelinek, Diane F., Ansell, Stephen M. , Fernández-Zapico, Martín E. , Feldman, Andrew L. , Luchtel, Rebecca A. , Law, Mark E. , O'Byrne, Megan M, Doǧan, Ahmet , Law, Mark E., Maurer, Matthew J. , Cerhan, James R. , Slager, Susan L. , Feldman, Andrew L , Elsawa, Sherine F , Link, Brian K , Lee, Jeong-Heon , Ketterling, Rhett P

Blood | April 2, 2015 | Volume: 125 | Issue: 20 | Pages: 3118-3127

10.1182/blood-2014-05-578575 | PMID 25833963 Get It

Key PointsThe NF-κB subunits p52 and RelB increase IRF4 promoter activity and expression in PTCL cells. A positive feedback loop involving CD30, NF-κB, and IRF4 drives PTCL cell proliferation and can be blocked by NF-κB inhibitors.
Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement
Suri, Rakesh M. , Rajeswaran, Jeevanantham , Babaliaros, Vasilis , Douglas, Pamela S. , Fearon, William F. , Miller, D. Craig , Kirtane, Ajay J. , Kodali, Susheel , Mack, Michael J. , Szeto, Wilson Y. , Thourani, Vinod H. , Tuzcu, E. Murat , Williams, Mathew , Akin, Jodi J., Leon, Martin B. , Svensson, Lars G. , Blackstone, Eugene H. , Mack, Michael, Williams, Mathew R, Hahn, Rebecca T , Kapadia, Samir , Douglas, Pamela S , Williams, Mathew

Circulation | April 2, 2015 | Volume: 131 | Issue: 22 | Pages: 1989-2000

10.1161/circulationaha.114.012525 | PMID 25832034 Get It

Background— The higher risk of adverse outcomes after transapical (TA) versus transfemoral (TF) transcatheter aortic valve replacement (TAVR) could be attributable to TA-TAVR being an open surgical procedure or to clinical differences between TA- and TF-TAVR patients. We compared outcomes after neutralizing patient differences using propensity score matching. Methods and Results— From April 2007 to February 2012, 1100 Placement of Aortic Transcatheter Valves (PARTNER)-I patients underwent TA-TAVR and 1521 underwent TF-TAVR with Edwards SAPIEN balloon-expandable bioprostheses. Propensity matching based on 111 preprocedural variables, exclusive of femoral access morphology, identified 501 well-matched patient pairs (46% of possible matches), 95% of whom had peripheral arterial disease. Matched TA-TAVR patients experienced more adverse procedural events, longer length of stay (5 versus 8 days; P <0.0001), and slower recovery (New York Heart Association class I, 31% versus 38% at 30 days, equalizing by 6 months at 51% versus 47%); stroke risk was similar (3.4% versus 3.3% at 30 days and 6.0% versus 6.7% at 3 years); mortality was elevated for the first 6 postprocedural months (19% versus 12%; P =0.01); but aortic regurgitation was less (34% versus 52% mild and 8.9% versus 12% moderate to severe at discharge, P =0.001; 36% versus 50% mild and 10% versus 15% moderate to severe at 6 months, P <0.0001). Conclusions— The likelihood of adverse periprocedural events and prolonged recovery is greater after TA-TAVR than TF-TAVR in vasculopathic patients after accounting for differences in cardiovascular risk factors, although stroke risk is equivalent and aortic regurgitation is less. As smaller delivery systems permit TF-TAVR in many of these patients, we recommend a TF-first access strategy for TAVR when anatomically feasible. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00530894.
Role of Cation Channel TRPV4 in Mechanosensing, Myofibroblast Differentiation, and Pulmonary Fibrosis
Grove, L. , Southern, Brian D. , Abraham, Susamma , Niese, Kathryn A., Ghosh, Sudakshina, Tschumperlin, Daniel J. , Olman, Mitchell A. , Rahaman, Shaik O. , Scheraga, Rachel Greenberg

Annals of the American Thoracic Society | April 2, 2015 | Volume: 12 | Issue: Supplement_1 | Pages: S74-S75

10.1513/annalsats.201411-531mg Get It

Matrix, Mesenchyme, and Mechanotransduction
Tschumperlin, Daniel J.

Annals of the American Thoracic Society | April 2, 2015 | Volume: 12 | Issue: Supplement_1 | Pages: S24-S29

10.1513/annalsats.201407-320mg | PMID 25830830 Get It

Abstract The extracellular matrix (ECM) of the lung serves as both a scaffold for resident cells and a mechanical support for respiratory function. The ECM is deposited during development and undergoes continuous turnover and maintenance during organ growth and homeostasis. Cells of the mesenchyme, including the tissue resident fibroblast, take a leading role in depositing and organizing the matrix and do so in an anatomically distinct fashion, with differing composition, organization, and mechanical properties within the airways, vessels, and alveoli of the lung. Recent technological advancements have allowed the lung’s ECM biochemical composition and mechanical properties to be studied with improved resolution, thereby identifying novel disease-related changes in ECM characteristics. In parallel, efforts to study cells seeded on normal and disease-derived matrices have illustrated the powerful role the ECM can play in altering key functions of lung resident cells. The mechanical properties of the matrix have been identified as an important modifier of cell–matrix adhesions, with matrices of pathologic stiffness promoting profibrotic signaling and cell function. Ongoing work is identifying both mechanically activated pathways in mesenchymal cells and disease-related ECM molecules that biochemically regulate cell function. Uncovering the control systems by which cells respond to and regulate the matrix, and the failures in these systems that underlie aberrant repair, remains a major challenge. Progress in this area will be an essential element in efforts to engineer functional lung tissue for regenerative approaches and will be key to identifying new therapeutic strategies for lung diseases characterized by disturbed matrix architecture.
Modulation of TRIM72 Alters the Repair Capacity of Lung Epithelial Cells
Kim, Seong Chul, Kellett, Thomas, Nishi, Miyuki , Zhou, Beiyun , Flodby, Per , Takeshima, Hiroshi , Hubmayr, Rolf D., Zhao, Xiaoli , Wang, Shaohua , Nagre, Nagaraja N. , Shilo, Konstantin , Ghadiali, Samir N.

Annals of the American Thoracic Society | April 2, 2015 | Volume: 12 | Issue: Supplement_1 | Pages: S72-S72

10.1513/annalsats.201406-277mg Get It

Metformin does not improve survival of cholangiocarcinoma patients with diabetes
Zhang, Xiaodan , Roberts, Rosebud O., Roberts, Lewis R. , Chaiteerakij, Roongruedee , Yang, Zhen , Chaiteerakij, Roongruedee , Roberts, Lewis R

Hepatology | April 1, 2015 | Volume: 63 | Issue: 2 | Pages: 667-668

10.1002/hep.27821 | PMID 25833233 Get It

Standardized Outcome and Reporting Measures in Pediatric Head and Neck Lymphatic Malformations
Balakrishnan, Karthik , Bauman, Nancy M. , Darrow, David H., Grimmer, J. Fredrik , Richter, Gresham T. , Shin, Jennifer J. , Shivaram, Giridhar M. , Sidell, Douglas R. , Elluru, Ravindhra G., Sidell, Douglas R. , Chun, Robert H. , Perkins, Jonathan A. , Sidell, Douglas R , Balakrishnan, Karthik

Otolaryngology–Head and Neck Surgery | April 1, 2015 | Volume: 152 | Issue: 5 | Pages: 948-953

10.1177/0194599815577602 | PMID 25829389 Get It

ObjectiveTo develop general and site‐specific treatment effect and outcome measures to standardize the reporting of head and neck lymphatic malformation (HNLM) treatments.Study DesignConsensus statement/expert opinion.SettingMultiple tertiary academic institutions.Subjects and MethodsThe modified Delphi method is an iterative process of collecting expert opinions, refining opinions through discussion and feedback, statistically aggregating opinions, and using these aggregates to generate consensus opinion in the absence of other data. The modified Delphi method was used by a multi‐institutional group of otolaryngology and interventional radiology experts in the field of vascular anomalies to formulate a list of recommended reporting outcomes for the study and treatment of head and neck lymphatic malformations.ResultsThrough 3 rounds of iteration, 10 expert panelists refined 98 proposed outcome measures and 9 outcome categories to a final consensus set of 50 recommended outcome measures in 3 global categories (general, demographics, and treatment complications) and 5 site‐specific categories (orbit, oral cavity, pharynx, larynx, and neck).ConclusionsWe propose the first consensus set of standardized reporting measures for clinical and treatment outcomes in studies of HNLMs. Consistent outcome measures across future studies will facilitate comparison of treatment options and allow systematic review. We hope that these guidelines facilitate the design and reporting of subsequent HNLM studies.
A meta‐analysis of immunogenetic Case–Control Association Studies in irritable bowel syndrome
Schmitteckert, Stefanie , Houghton, Lesley A. , Sayuk, Gregory S. , Camilleri, Michael , Olivo‐Díaz, Angélica , Spiller, Robert E. , Wouters, Mira M. , Bermejo, J Lorenzo, Niesler, Beate , Czogalla, Bastian , Boeckxstaens, Guy E. , Houghton, L A , Spiller, Robin

Neurogastroenterology & Motility | April 1, 2015 | Volume: 27 | Issue: 5 | Pages: 717-727

10.1111/nmo.12548 | PMID 25824902 Get It

AbstractBackgroundTo date, genetic‐association studies of single nucleotide polymorphisms (SNP) in selected candidate genes with the symptom phenotype of irritable bowel syndrome (IBS) have typically involved hundreds to 2000 patients. SNPs in immune‐related genes, such as cytokine and cytokine receptor encoding genes, have been reported to associate with IBS risk.MethodsWe conducted two independent case–control studies on 16 SNPs in IL1R1, IL4, IL6, IL8, IL10, IL23R, TNFA, and TNFSF15, one from the UK (194 patients and 92 healthy volunteers) and one from the USA (137 patients and 96 healthy volunteers). The main aim was to examine the relationship between inherited immunological diversity and IBS risk in a meta‐analysis which included 12 additional, earlier studies. The meta‐analysis comprised a total of 2894 patients (839 IBS‐C, 1073 IBS‐D, 502 IBS‐M), and 3138 healthy volunteers with self‐reported Caucasian ancestry.Key ResultsThe association of SNP rs4263839 (TNFSF15) was investigated in four studies and confirmed in the meta‐analysis: IBS (OR 1.19, 95% CI 1.08–1.31), and IBS‐C (OR 1.24, 95% CI 1.08–1.42). No additional SNPs residing in immunogenes associated with IBS symptom phenotypes.Conclusions & InferencesOur meta‐analysis could not confirm a major role of most investigated SNPs, but a moderate association between rs4263839 TNFSF15 and IBS, in particular IBS‐C. The analysis emphasizes the importance of definition and phenotype homogeneity, adequate study size and representativeness of the patient and control collective.
Incorporating approximate rotational invariance into two‐dimensional S‐transform
Cheng, Chun Hing , Pradhan, Pyari Mohan , Mitchell, J. Ross

IET Image Processing | April 1, 2015 | Volume: 9 | Issue: 7 | Pages: 535-544

10.1049/iet-ipr.2014.0765 Get It

The discrete two‐dimensional (2D) S‐transform (ST‐2D) is a space‐frequency representation that provides the local spectrum at each pixel in an image. The inherent localisation properties of the ST‐2D make it a preferred candidate for space‐frequency analysis. However, the ST‐2D is sensitive to the image rotation. This limits its use in many image processing applications such as texture analysis. This study describes the rotational sensitivity of the ST‐2D, and explains how this limits its application. To overcome these problems, a novel rotationally invariant S‐transform (RIST) is formulated, and its rotational invariance is investigated. The RIST can provide approximate rotational invariance for magnitudes and complex values over a wide range of rotation angles, but with a trade‐off of higher computation time. The RIST may be useful for many medical, scientific and industrial applications.
Regulation of Increased Blood Flow (Hyperemia) to Muscles During Exercise: A Hierarchy of Competing Physiological Needs
Joyner, Michael J. , Casey, Darren P. , Joyner, Michael J

Physiological Reviews | April 1, 2015 | Volume: 95 | Issue: 2 | Pages: 549-601

10.1152/physrev.00035.2013 | PMID 25834232 Get It

This review focuses on how blood flow to contracting skeletal muscles is regulated during exercise in humans. The idea is that blood flow to the contracting muscles links oxygen in the atmosphere with the contracting muscles where it is consumed. In this context, we take a top down approach and review the basics of oxygen consumption at rest and during exercise in humans, how these values change with training, and the systemic hemodynamic adaptations that support them. We highlight the very high muscle blood flow responses to exercise discovered in the 1980s. We also discuss the vasodilating factors in the contracting muscles responsible for these very high flows. Finally, the competition between demand for blood flow by contracting muscles and maximum systemic cardiac output is discussed as a potential challenge to blood pressure regulation during heavy large muscle mass or whole body exercise in humans. At this time, no one dominant dilator mechanism accounts for exercise hyperemia. Additionally, complex interactions between the sympathetic nervous system and the microcirculation facilitate high levels of systemic oxygen extraction and permit just enough sympathetic control of blood flow to contracting muscles to regulate blood pressure during large muscle mass exercise in humans.